Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Garret M K, Leung"'
Autor:
Harinder Gill, Rita Yim, Herbert H. Pang, Paul Lee, Thomas S. Y. Chan, Yu‐Yan Hwang, Garret M. K. Leung, Ho‐Wan Ip, Rock Y. Y. Leung, Sze‐Fai Yip, Bonnie Kho, Harold K. K. Lee, Vivien Mak, Chi‐Chung Chan, June S. M. Lau, Chi‐Kuen Lau, Shek‐Yin Lin, Raymond S. M. Wong, Wa Li, Edmond S. K. Ma, Jun Li, Gianni Panagiotou, Joycelyn P. Y. Sim, Albert K. W. Lie, Yok‐Lam Kwong
Publikováno v:
Cancer Medicine, Vol 9, Iss 10, Pp 3371-3382 (2020)
Abstract Clofarabine is active in refractory/relapsed acute myeloid leukemia (AML). In this phase 2 study, we treated 18‐ to 65‐year‐old AML patients refractory to first‐line 3 + 7 daunorubicin/cytarabine induction or relapsing after 3 + 7 in
Externí odkaz:
https://doaj.org/article/2744c5249b7a4f84a43188e34f729a01
Autor:
Thomas S. Y. Chan, Albert K. W. Lie, Joycelyn P Y Sim, Eric Tse, Yok-Lam Kwong, Garret M. K. Leung, Yu-Yan Hwang
Publikováno v:
Annals of Hematology. 101:155-163
Graft-versus-host disease (GVHD) is an important complication after allogeneic haematopoietic stem cell transplantation (HSCT). Corticosteroids are the standard first-line treatment. Steroid-resistant/-dependent (SR/D) acute and chronic GVHD (aGVHD,
Autor:
Gianni Panagiotou, Thomas S. Y. Chan, Paul P. Lee, Bonnie Kho, Sze-Fai Yip, Chi-Kuen Lau, Wa Li, Herbert Pang, Vivien Mak, Joycelyn Sim, Edmond S. K. Ma, Yok-Lam Kwong, Harold K. K. Lee, Rita Yim, Ho-Wan Ip, Raymond S.M. Wong, Albert K. W. Lie, Shek‐Yin Lin, Harinder Gill, June S. M. Lau, Jun Li, Chi-Chung Chan, Yu-Yan Hwang, Rock Y. Y. Leung, Garret M. K. Leung
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 9, Iss 10, Pp 3371-3382 (2020)
Cancer Medicine, Vol 9, Iss 10, Pp 3371-3382 (2020)
Clofarabine is active in refractory/relapsed acute myeloid leukemia (AML). In this phase 2 study, we treated 18‐ to 65‐year‐old AML patients refractory to first‐line 3 + 7 daunorubicin/cytarabine induction or relapsing after 3 + 7 induction a
Autor:
Garret M K, Leung, Joycelyn P Y, Sim, Yu-Yan, Hwang, Thomas S Y, Chan, Albert K W, Lie, Eric, Tse, Yok-Lam, Kwong
Publikováno v:
Annals of hematology. 101(1)
Graft-versus-host disease (GVHD) is an important complication after allogeneic haematopoietic stem cell transplantation (HSCT). Corticosteroids are the standard first-line treatment. Steroid-resistant/-dependent (SR/D) acute and chronic GVHD (aGVHD,
Publikováno v:
Annals of Hematology. 98:215-218
Autor:
Sze‐Pui Tsui, Ning Yang, T. K. Chan, Wa Li, Ho-Wan Ip, Chun Hang Au, Stephen S. Y. Lam, Sze-Fai Yip, Chunxiao Zhang, Yok-Lam Kwong, Nelson K. L. Ng, Edmond S. K. Ma, June S. M. Lau, Anskar Y.H. Leung, Harold K. K. Lee, Tsan-Hei Luk, Garret M. K. Leung
Publikováno v:
CancerReferences. 126(2)
Background Omacetaxine mepesuccinate (OME) has antileukemic effects against acute myeloid leukemia (AML) carrying an internal tandem duplication of Fms-like tyrosine kinase 3 (FLT3-ITD). A phase 2 clinical trial was conducted to evaluate a combinatio
Autor:
Anskar Y.H. Leung, Ning Yang, Ho W Ip, Bonnie Kho, Jason C. C. So, Kelvin C K Cheng, Edmond S. K. Ma, Nelson K. L. Ng, Tsun Leung Chan, Shek Y Lin, Sze F Yip, Sze P Tsui, Margaret H.L. Ng, Stephen S. Y. Lam, Chunxiao Zhang, Harold K. K. Lee, June S. M. Lau, Kit Fai Wong, Tsan H Luk, Lisa L. P. Siu, Garret M. K. Leung, Yok L. Kwong, Chi K Lau, Chun H Au
Publikováno v:
American journal of hematology. 94(6)
The present study aimed to define a subtype of complex/monosomal karyotype (CK/MK) acute myeloid leukemia (AML) by its distinct clinical features, p53 signaling and responses to p53 targeting agents. Ninety-eight young adults (range: 21-60 years; med
Autor:
Garret M. K. Leung, Gianni Panagioutou, Ho-Wan Ip, Clarence C.K. Lam, Jason C. C. So, Herbert Pang, Paul P. Lee, Rita Yim, Rock Y. Y. Leung, WF Tang, Karen Tang, Yok-Lam Kwong, Jun Li, Harinder Gill, Jamilla Li
Publikováno v:
Annals of hematology. 98(4)
Current prognostication in myelofibrosis (MF) is based on clinicopathological features and mutations in a limited number of driver genes. The impact of other genetic mutations remains unclear. We evaluated for mutations in a myeloid panel of 54 genes
Autor:
Qing Liu, Christopher Chan, Chunxiao Zhang, Sze Pui Tsui, Ho-Wan Ip, Garret M. K. Leung, Harold K. K. Lee, Anskar Y.H. Leung, Thomas Wing Yan Leung, Bonnie Kho, Yok-Lam Kwong, Chun Hang Au, Sze Fai Yip, Edmond S. K. Ma, Ka Lam Nelson Ng
Publikováno v:
Blood. 134:3825-3825
Objectives: Acute myeloid leukemia (AML) carrying internal tandem duplication (ITD) of Fms-Like Tyrosine Kinase 3 (FLT3) is associated with high relapse risk and adverse outcome. This single-arm, phase 2 study evaluated efficacy and safety of combina
Publikováno v:
British journal of haematology. 176(6)